Concepedia

Morgan Sturgeon

MS

Statistics

Publications

5

Citations

478

H-Index

5

Active since

2018

Affiliations

Integrated DNA Technologies (United States)(Current)

University of Iowa

Morgan Sturgeon is an author at Integrated DNA Technologies (United States) specializing in genome editing, life sciences, and pharmacology.

ORCID

Publications per year

2018–2025

5

Publications

5

Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease

Kiran Musunuru, Sarah Grandinette, Xiao Wang et al. · New England Journal of Medicine · 2025 · 278 citations · Full text

, , +17

Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells

Jonas Kath, Weijie Du, Alina Pruene et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 95 citations · Full text

, , +17

Drug repositioning in epilepsy reveals novel antiseizure candidates

Leo Brueggeman, Morgan Sturgeon, Russell Martin et al. · Annals of Clinical and Translational Neurology · 2018 · 51 citations · Full text

, , +14

CRISPAltRations: A validated cloud-based approach for interrogation of double-strand break repair mediated by CRISPR genome editing

Gavin Kurgan, Rolf Turk, Heng Li et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 35 citations · Full text

, , +16

The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models

Morgan Sturgeon, Rachel Langton, Shaunik Sharma et al. · Epilepsia Open · 2021 · 19 citations · Full text

, , +14

1–5 of 5